Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection

Programmed death-ligand 1 (PD-L1) plays an essential protein for immune evasion, contributing to tumor development and progression. Recent studies have reported MET as an upregulator for PD-L1 overexpression through an oncogenic pathway. However, an association between PD-L1 expression with MET has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Mi Jung, Kim, Kab-Choong, Nam, Eun Sook, Cho, Seong Jin, Park, Hye-Rim, Min, Soo Kee, Seo, Jinwon, Choe, Ji-Young, Lee, Hye Kyung, Kang, Ho Suk, Min, Kyueng-Whan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669899/
https://www.ncbi.nlm.nih.gov/pubmed/29137273
http://dx.doi.org/10.18632/oncotarget.19390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669899/
https://www.ncbi.nlm.nih.gov/pubmed/29137273
http://dx.doi.org/10.18632/oncotarget.19390

Ejemplares similares